Approval · Notice of Compliance 5709 · 1994
GEMFIBROZIL: Notice of Compliance 5709
Issued October 5, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5709
- Date
- October 5, 1994
- Company
- Laboratoires Pro Doc Limitée
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihyperlipidemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEMFIBROZIL | 02136031 | Cancelled Post Market |
| GEMFIBROZIL | 02136058 | Cancelled Post Market |
Medicinal ingredients
- GEMFIBROZIL 300 MG per CAP
- GEMFIBROZIL 600 MG per CAP